180 related articles for article (PubMed ID: 25327303)
1. Meloxicam temporally inhibits the expression of vascular endothelial growth factor receptor (VEGFR)-1 and VEGFR-2 during alveolar bone repair in rats.
Arantes RV; Cestari TM; Viscelli BA; Dionísio TJ; Garlet GP; Santos CF; de Assis GF; Taga R
J Periodontol; 2015 Jan; 86(1):162-72. PubMed ID: 25327303
[TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats.
Oliveira TM; Sakai VT; Machado MA; Dionísio TJ; Cestari TM; Taga R; Amaral SL; Santos CF
J Periodontol; 2008 Jun; 79(6):1062-9. PubMed ID: 18533784
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
Quintana R; Kopcow L; Marconi G; Young E; Yovanovich C; Paz DA
Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
[TBL] [Abstract][Full Text] [Related]
4. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair.
Colwell AS; Beanes SR; Soo C; Dang C; Ting K; Longaker MT; Atkinson JB; Lorenz HP
Plast Reconstr Surg; 2005 Jan; 115(1):204-12. PubMed ID: 15622252
[TBL] [Abstract][Full Text] [Related]
5. The effect of simvastatin on mRNA expression of transforming growth factor-beta1, bone morphogenetic protein-2 and vascular endothelial growth factor in tooth extraction socket.
Liu C; Wu Z; Sun HC
Int J Oral Sci; 2009 Jun; 1(2):90-8. PubMed ID: 20687301
[TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats.
Gurgel BCV; Almeida KT; Peixoto RF; Lima KC; Kantovitz KR; Humberto F; Toledo S
Braz Dent J; 2017; 28(2):135-139. PubMed ID: 28492740
[TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model.
Pufe T; Scholz-Ahrens KE; Franke AT; Petersen W; Mentlein R; Varoga D; Tillmann B; Schrezenmeir J; Glüer CC
Bone; 2003 Dec; 33(6):869-76. PubMed ID: 14678846
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factors and receptors are up-regulated during development of apical periodontitis.
Bletsa A; Virtej A; Berggreen E
J Endod; 2012 May; 38(5):628-35. PubMed ID: 22515891
[TBL] [Abstract][Full Text] [Related]
9. Effect of aluminum oxide-blasted implant surface on the bone healing around implants in rats submitted to continuous administration of selective cyclooxygenase-2 inhibitors.
Ribeiro FV; Nociti FH; Sallum EA; Casati MZ
Int J Oral Maxillofac Implants; 2009; 24(2):226-33. PubMed ID: 19492637
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulin-like growth factor I on alveolar bone remodeling in diabetic rats.
Fang Y; Wang LP; Du FL; Liu WJ; Ren GL
J Periodontal Res; 2013 Apr; 48(2):144-50. PubMed ID: 22834984
[TBL] [Abstract][Full Text] [Related]
11. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
12. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.
Kim SJ; Seo JH; Lee YJ; Yoon JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Oncology; 2005; 68(2-3):204-11. PubMed ID: 16015035
[TBL] [Abstract][Full Text] [Related]
13. Meloxicam as a Radiation-Protective Agent on Mandibles of Irradiated Rats.
Yamasaki MC; Nejaim Y; Roque-Torres GD; Freitas DQ
Braz Dent J; 2017; 28(2):249-255. PubMed ID: 28492757
[TBL] [Abstract][Full Text] [Related]
14. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
Bezerra MM; de Lima V; Alencar VB; Vieira IB; Brito GA; Ribeiro RA; Rocha FA
J Periodontol; 2000 Jun; 71(6):1009-14. PubMed ID: 10914805
[TBL] [Abstract][Full Text] [Related]
15. Effect of meloxicam and diclofenac sodium on peri-implant bone healing in rats.
Pablos AB; Ramalho SA; König B; Furuse C; de Araújo VC; Cury PR
J Periodontol; 2008 Feb; 79(2):300-6. PubMed ID: 18251644
[TBL] [Abstract][Full Text] [Related]
16. TGF-β1 and BMP-4 carried by liposomes enhance the healing process in alveolar bone.
Ferreira CL; Abreu FA; Silva GA; Silveira FF; Barreto LB; Paulino Tde P; Miziara MN; Alves JB
Arch Oral Biol; 2013 Jun; 58(6):646-56. PubMed ID: 23290003
[TBL] [Abstract][Full Text] [Related]
17. Selective COX-2 inhibitor reduces bone healing in bone defects.
Gurgel BC; Ribeiro FV; Silva MA; Nociti FH; Sallum AW; Sallum EA; Toledo Sd; Casati MZ
Braz Oral Res; 2005; 19(4):312-6. PubMed ID: 16491262
[TBL] [Abstract][Full Text] [Related]
18. Histometric study of alveolar bone healing in rats treated with the nonsteroidal anti-inflammatory drug nimesulide.
Teófilo JM; Giovanini GS; Fracon RN; Lamano T
Implant Dent; 2011 Apr; 20(2):e7-13. PubMed ID: 21448017
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin promotes bone formation during the alveolar healing process in old acyclic female rats.
Colli VC; Okamoto R; Spritzer PM; Dornelles RC
Arch Oral Biol; 2012 Sep; 57(9):1290-7. PubMed ID: 22525945
[TBL] [Abstract][Full Text] [Related]
20. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
